Trevi Therapeutics (TRVI) Stock: Why It Fell Over 3.3% After Hours

By Amit Chowdhry ● Sep 23, 2022
  • The stock price of Trevi Therapeutics (TRVI) fell by over 3.3% after hours in the most recent trading session. This is why.

The stock price of Trevi Therapeutics (TRVI) fell by over 3.3% after hours in the most recent trading session. 

Why: Offering revealed in a regulatory filing

“We are also offering, in lieu of common stock to certain investors that so choose, warrants to purchase shares of our common stock, which we refer to as pre-funded warrants. The purchase price of each pre-funded warrant equals the price per share at which shares of our common stock are being sold to the public in this offering, minus $0.001, and the exercise price of each pre-funded warrant equals $0.001 per share. This prospectus supplement also relates to the offering of the shares of our common stock issuable upon the exercise of such pre-funded warrants,” said the company in the filing.